Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IODOBENZAMIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lobbezoo, F; Rompre, PH; Soucy, JP; Iafrancesco, C; Turkewicz, J; Montplaisir, JY; Lavigne, GJ
      Lack of associations between occlusal and cephalometric measures, side imbalance in striatal D2 receptor binding, and sleep-related oromotor activities

      JOURNAL OF OROFACIAL PAIN
    2. Tranquart, F; Saliba, E; Barantin, L; Lanneau, M; Simmer, L; Guilloteau, D; Baulieu, JL
      D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT

      CLINICAL NUCLEAR MEDICINE
    3. Lavigne, GJ; Soucy, JP; Lobbezoo, F; Manzini, C; Blanchet, PJ; Montplaisir, JY
      Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism

      CLINICAL NEUROPHARMACOLOGY
    4. Chehade, F; De Labriolle-Vaylet, C; Michelot, J; Moins, N; Moreau, MF; Hindie, E; Papon, J; Escaig, F; Galle, P; Veyre, A
      Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: A study by secondary ion mass spectroscopy

      CELLULAR AND MOLECULAR BIOLOGY
    5. Schroder, J; Bubeck, B; Sauer, H
      D-2-dopamine receptor upregulation and treatment response under neuroleptic therapy

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    6. Schommartz, B; Larisch, R; Vosberg, H; Muller-Gartner, HW
      Striatal dopamine release in reading and writing measured with [I-123]iodobenzamide and single photon emission computed tomography in right handed human subjects

      NEUROSCIENCE LETTERS
    7. Gouhier, C; Chalon, S; Venier-Julienne, MC; Bodard, S; Benoit, JP; Besnard, JC; Guilloteau, D
      Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide

      NEUROSCIENCE LETTERS
    8. Zea-Ponce, Y; Laruelle, M
      Synthesis of [I-123]IBZM: A reliable procedure for routine clinical studies

      NUCLEAR MEDICINE AND BIOLOGY
    9. Klimke, A; Larisch, R; Janz, A; Vosberg, H; Muller-Gartner, HW; Gaebel, W
      Dopamine D-2 receptor binding before and after treatment of major depression measured by [I-123]IBZM SPECT

      PSYCHIATRY RESEARCH-NEUROIMAGING
    10. Dresel, S; Mager, T; Rossmuller, B; Meisenzahl, E; Hahn, K; Moller, HJ; Tatsch, K
      In vivo effects of olanzapine on striatal dopamine D-2/D-3 receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    11. Baulieu, JL; Ribeiro, MJ; Levilion-Prunier, C; Tranquart, F; Chartier, JR; Guilloteau, D; Cottier, JP; Besnard, JC; Pourcelot, L; Autret, A
      Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using I-123-iodolisuride SPET

      NUCLEAR MEDICINE COMMUNICATIONS
    12. Grunder, G; Muller, MJ; Andreas, J; Heydari, N; Wetzel, H; Schlosser, R; Schlegel, S; Nickel, O; Eissner, D; Benkert, O
      Occupancy of striatal D-2-like dopamine receptors after treatment with thesigma ligand EMD 57445, a putative atypical antipsychotic

      PSYCHOPHARMACOLOGY
    13. MOREAU MF; LABARRE P; FOUCAUD A; SEGUIN H; BAYLE M; PAPON J; MADELMONT JC
      RADIOSYNTHESIS OF NO-CARRIER-ADDED N-(4-DIPROPYLAMINOBUTYL)-4-[I-125]-IODOBENZAMIDE, A PROMISING TRACER FOR THE DETECTION OF MELANOMA

      Journal of labelled compounds & radiopharmaceuticals
    14. Usuki, E; Van der Schyf, CJ; Castagnoli, N
      Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP

      DRUG METABOLISM REVIEWS
    15. DRESEL S; TATSCH K; DAHNE I; MAGER T; SCHERER J; HAHN K
      IODINE-123-IODOBENZAMIDE SPECT ASSESSMENT OF DOPAMINE D-2 RECEPTOR OCCUPANCY IN RISPERIDONE-TREATED SCHIZOPHRENIC-PATIENTS

      The Journal of nuclear medicine
    16. HIERHOLZER J; CORDES M; VENZ S; SCHELOSKY L; HARISCH C; RICHTER W; KESKE U; HOSTEN N; MAURER J; POEWE W; FELIX R
      LOSS OF DOPAMINE-D2 RECEPTOR-BINDING SITES IN PARKINSONIAN PLUS SYNDROMES

      The Journal of nuclear medicine
    17. LARISCH R; SCHULTE KW; VOSBERG H; RUZICKA T; MULLERGARTNER HW
      DIFFERENTIAL ACCUMULATION OF IODINE-123-IODOBENZAMIDE IN MELANOTIC AND AMELANOTIC MELANOMA METASTASES IN-VIVO

      The Journal of nuclear medicine
    18. KAPUCU LO; KOC E; GUCUYENER K; ZENCIROGLU A; ATALAY Y; UNLU M; VANROYEN E
      D-2 RECEPTOR IMAGING WITH IODINE-123-IODOBENZAMIDE BRAIN SPECT IN INFANTS WITH HYPOXIC-ISCHEMIC BRAIN INJURY

      The Journal of nuclear medicine
    19. LARISCH R; KLIMKE A
      ON THE CLINICAL IMPACT OF CEREBRAL DOPAMINE D-2 RECEPTOR SCINTIGRAPHY

      Nuklearmedizin
    20. BONI R; LICHTENSTEIGER W; STEINERT HC; BONI RAH; FRUH H; DUMMER R; HARTMANN DG; LAINE E; BURG G
      D1 DOPAMINE-RECEPTORS ARE NOT EXPRESSED IN HUMAN-MELANOMA

      Melanoma research
    21. SCHWARZ J; TATSCH K; GASSER T; ARNOLD G; OERTEL WH
      [(123)]IBZM BINDING PREDICTS DOPAMINERGIC RESPONSIVENESS IN PATIENTS WITH PARKINSONISM AND PREVIOUS DOPAMINOMIMETIC THERAPY

      Movement disorders
    22. WALKER Z; COSTA DC; JANSSEN AG; WALKER RWH; LIVINGSTONE G; KATONA CLE
      DEMENTIA WITH LEWY BODIES - A STUDY OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS WITH I-123 IODOBENZAMIDE SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    23. BOOIJ J; KORN P; LINSZEN DH; VANROYEN EA
      ASSESSMENT OF ENDOGENOUS DOPAMINE RELEASE BY METHYLPHENIDATE CHALLENGE USING I-123 IODOBENZAMIDE SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    24. ACTON PD; PILOWSKY LS; SUCKLING J; BRAMMER MJ; ELL PJ
      REGISTRATION OF DYNAMIC DOPAMINE D-2 RECEPTOR IMAGES USING PRINCIPAL COMPONENT ANALYSIS

      European journal of nuclear medicine
    25. HERTEL A; WEPPNER M; BAAS H; SCHREINER M; MAUL FD; BAUM RP; FISCHER PA; HOR G
      QUANTIFICATION OF IBZM DOPAMINE-RECEPTOR SPET IN DE-NOVO PARKINSON PATIENTS BEFORE AND DURING THERAPY

      Nuclear medicine communications
    26. MULLER TH; EISING EG; REINERS C; PRZUNTEK H; JACOB M; KUHN W
      2-[I-123]-IODOLISURIDE SPET VISUALIZES DOPAMINERGIC LOSS IN DE-NOVO PARKINSONIAN-PATIENTS - IS IT A MARKER OF STRIATAL PRESYNAPTIC DEGENERATION

      Nuclear medicine communications
    27. LOBBEZOO F; SOUCY JP; HARTMAN NG; MONTPLAISIR JY; LAVIGNE GJ
      EFFECTS OF THE D2 RECEPTOR AGONIST BROMOCRIPTINE ON SLEEP BRUXISM - REPORT OF 2 SINGLE-PATIENT CLINICAL-TRIALS

      Journal of dental research
    28. HENKER C; BIDA B; MARKWARDT J; SCHLAG P
      DIAGNOSTIC-VALUE OF (123)IODINE-IBZM-SCIN TIGRAPHY FOR STAGING OF MALIGNANT MELANOMAS

      Nuklearmedizin
    29. BONI R; STEINERT H; BONI RAH; LICHTENSTEIGER W; DUMMER R; HARTMAN DS; VONSCHULTHESS GK; BURG G; WESTERA G
      LACK OF EXPRESSION OF DOPAMINE D2 RECEPTORS IN MALIGNANT-MELANOMA - EVIDENCE FOR INTERACTION OF IODOBENZOFURANS WITH MELANIN

      Dermatology
    30. PELLEVOISIN C; GUILLOTEAU D; BAULIEU JL; LOCH C; DOGNON AM; MAUCLAIRE L; SACCAVINI JC; BESNARD JC; CHALON S
      IODALISURIDE AND IODOBENZAMIDE, 2 LIGANDS FOR SPECT EXPLORATION OF THE DOPAMINERGIC D2 RECEPTORS - A COMPARATIVE-STUDY

      Synapse
    31. VANDERSCHYF CJ; DORMEHL IC; OLIVER DW; HUGO N; KEEVE R; MULLERGARTNER HW; POND SM; CASTAGNOLI N
      LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY

      Molecular brain research
    32. SCHWARZ J; OERTEL WH; TATSCH K
      IODINE-123-IODOBENZAMIDE BINDING IN PARKINSONISM - REDUCTION BY DOPAMINE AGONISTS BUT NOT L-DOPA

      The Journal of nuclear medicine
    33. CHEHADE F; MICHELOT J; HINDIE E; PAPON J; DELABRIOLLEVAYLET C; ZHANG LL; ESCAIG F; MOREAU MF; VEYRE A
      LOCALIZATION OF N-(2-DIETHYLAMINOETHYL)4-IODOBENZAMIDE IN THE PIGMENTED MOUSE EYE - A MICROANALYTICAL STUDY

      Cellular and molecular biology
    34. LOBBEZOO F; SOUCY JP; MONTPLAISIR JY; LAVIGNE GJ
      STRIATAL D2 RECEPTOR-BINDING IN SLEEP BRUXISM - A CONTROLLED-STUDY WITH IODINE-123-IODOBENZAMIDE AND SINGLE-PHOTON-EMISSION COMPUTED-TOMOGRAPHY

      Journal of dental research
    35. SCHLEGEL S; SCHLOSSER R; HIEMKE C; NICKEL O; BOCKISCH A; HAHN K
      PROLACTIN PLASMA-LEVELS AND D-2-DOPAMINE RECEPTOR OCCUPANCY MEASURED WITH IBZM-SPECT

      Psychopharmacology
    36. BRUCKE T; WOBER C; PODREKA I; WOBERBINGOL C; ASENBAUM S; AULL S; WENGER S; ILIEVA D; HARASKOVANDERMEER C; WESSELY P; DEECKE L
      D-2 RECEPTOR BLOCKADE BY FLUNARIZINE AND CINNARIZINE EXPLAINS EXTRAPYRAMIDAL SIDE-EFFECTS - A SPECT STUDY

      Journal of cerebral blood flow and metabolism
    37. NADEAU SE; COUCH MW; DEVANE CL; SHUKLA SS
      REGIONAL-ANALYSIS OF D2 DOPAMINE-RECEPTORS IN PARKINSONS-DISEASE USING SPECT AND IODINE-123-IODOBENZAMIDE

      The Journal of nuclear medicine
    38. REICHE W; GRUNDMANN M; HUBER G
      DOPAMINE D-2-RECEPTOR SPECT WITH [I-123] IODOBENZAMIDE IN THE DIAGNOSIS OF PARKINSONS SYNDROME

      Radiologe
    39. BALDWIN RM; ZEAPONCE Y; ZOGHBI SS; ALTIKRITI MS; SEIBYL JP; SYBIRSKA EH; MALISON RT; LARUELLE M; CHARNEY DS; HOFFER PB; INNIS RB
      PHARMACOKINETICS OF THE 3 RADIOIODINATED DOPAMINE D-2 RECEPTOR LIGANDS [I-123] IBF, [I-123] EPIDEPRIDE AND [I-123] 2'-ISP IN NONHUMAN-PRIMATES

      Nuclear medicine and biology
    40. KOEPP M; SCHELOSKY L; CORDES I; CORDES M; POEWE W
      DYSTONIA IN ATAXIA-TELANGIECTASIA - REPORT OF A CASE WITH PUTAMINAL LESIONS AND DECREASED STRIATAL [I-123] IODOBENZAMIDE BINDING

      Movement disorders
    41. PIRKER W; BRUCKE T; RIEDL M; CLODI M; LUGER A; ASENBAUM S; PODREKA I; DEECKE L
      IODINE-123-IBZM-SPECT - STUDIES IN 15 PATIENTS WITH PITUITARY-TUMORS

      Journal of neural transmission
    42. HIERHOLZER J; CORDES M; SCHELOSKY L; RICHTER W; KESKE U; VENZ S; SEMMLER W; POEWE W; FELIX R
      DOPAMINE D2 RECEPTOR IMAGING WITH IODINE-123-IODOBENZAMIDE SPECT IN IDIOPATHIC ROTATIONAL TORTICOLLIS

      The Journal of nuclear medicine
    43. OHMOMO Y; MURAKAMI K; HIRATA M; MAGATA Y; TANAKA C; YOKOYAMA A
      RADIOIODINATED N-(2-AMINOETHYL)-2-CHLORO-4-IODOBENZAMIDE - A NEW LIGAND FOR MONOAMINE-OXIDASE-B STUDIES WITH SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY

      Chemical and Pharmaceutical Bulletin
    44. VERHOEFF NPLG; SOKOLE EB; STABIN M; HENGST D; KUNG HF; VANROYEN EA; JANSSEN AGM
      DOSIMETRY OF I-123 IODOBENZAMIDE IN HEALTHY-VOLUNTEERS

      European journal of nuclear medicine
    45. NIKKINEN P; LIEWENDAHL K; SAVOLAINEN S; LAUNES J
      VALIDATION OF QUANTITATIVE BRAIN DOPAMINE-D2 RECEPTOR IMAGING WITH A CONVENTIONAL SINGLE-HEAD SPET CAMERA

      European journal of nuclear medicine
    46. VERHOEFF NPLG; VISSER WH; FERRARI MD; SAXENA PR; VANROYEN EA
      DOPAMINE-D2-RECEPTOR IMAGING WITH I-123 IODOBENZAMIDE SPECT IN MIGRAINE PATIENTS ABUSING ERGOTAMINE - DOES ERGOTAMINE CROSS THE BLOOD-BRAIN-BARRIER

      Cephalalgia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 05:24:18